BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Treatment
6544 results:

  • 1. Overweight as a biomarker for concomitant thyroid cancer in patients with Graves' disease.
    Park J; An S; Bae JS; Kim JS; Kim K
    Front Endocrinol (Lausanne); 2024; 15():1382124. PubMed ID: 38711981
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Active surveillance is a feasible and safe strategy in selected patients with papillary thyroid cancer and suspicious cervical lymph nodes detected after thyroidectomy.
    Solórzano M; Lustig N; Mosso L; Espinoza M; Santana R; Gonzalez H; Montero PH; Cruz F; Solar A; Domínguez JM
    Arch Endocrinol Metab; 2024 May; 68():e230146. PubMed ID: 38709151
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Genomic landscape and distinct molecular subtypes of primary testicular lymphoma.
    Zhang W; Yang P; Yang Y; Liu S; Xu Y; Wu C; Wang J; Liu C; Liu H; Li S; Huang W; Jing H
    J Transl Med; 2024 May; 22(1):414. PubMed ID: 38693538
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Efficacy and safety of neoadjuvant therapy in gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta-analysis.
    Yan Y; Wu D; Wang W; Lv Y; Yang L; Liu Y; Dong P; Yu X
    J Cancer Res Ther; 2024 Apr; 20(2):633-641. PubMed ID: 38687934
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The clinical value of iodine-125 seed implantation in the treatment of iodine-refractory differentiated thyroid carcinoma.
    Wan Q; Tan L; Tang X; Wang W; Su Y; Wu Z; Ke M; Chen Z
    Front Endocrinol (Lausanne); 2024; 15():1327766. PubMed ID: 38686207
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Assessment of Thyroid Carcinogenic Risk and Safety Profile of GLP1-RA Semaglutide (Ozempic) Therapy for Diabetes Mellitus and Obesity: A Systematic Literature Review.
    Feier CVI; Vonica RC; Faur AM; Streinu DR; Muntean C
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673931
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Persistent hypercalcaemia associated with two pathogenic variants in the
    Leszczyńska D; Szatko A; Latocha J; Kochman M; Duchnowska M; Wójcicka A; Misiorowski W; Zgliczyníski W; Glinicki P
    Front Endocrinol (Lausanne); 2024; 15():1355916. PubMed ID: 38665259
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Ultrasound and cytopathological characteristics of thyroid tumours of uncertain malignant potential - from diagnosis to treatment.
    Żyłka A; Dobruch-Sobczak K; Piotrzkowska-Wróblewska H; Jędrzejczyk M; Góralski P; Gałczyński J; Bakuła-Zalewska E; Dedecjus M
    Endokrynol Pol; 2024; 75(2):170-178. PubMed ID: 38646986
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Risk factors for postoperative fever after laparoscopic adrenalectomy focusing on hormones produced: a case control study.
    Izawa M; Takeda T; Anno T; Iwasawa T; Yasumizu Y; Tanaka N; Matsumoto K; Morita S; Kosaka T; Mizuno R; Asanuma H; Oya M
    BMC Urol; 2024 Apr; 24(1):90. PubMed ID: 38637748
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Long-Term Follow-up of Patients With Autonomous Thyroid Nodules Treated With Radioiodine.
    Moroto D; Torquato-Vieira ICO; Fiorin LB; Camacho CP; Castiglioni MLV; Maciel RMB; Furlanetto RP; Matsumura LK; Janovsky CCPS; Lindsey SC; Martins JRM
    Clin Nucl Med; 2024 Jun; 49(6):529-535. PubMed ID: 38619976
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. treatment patterns and survival outcomes in patients with non-metastatic early-onset pancreatic cancer.
    Zhang LT; Zhang Y; Cao BY; Wu CC; Wang J
    World J Gastroenterol; 2024 Mar; 30(12):1739-1750. PubMed ID: 38617739
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Common misconceptions and myths about ovarian cancer causation: a national cross-sectional study from palestine.
    Elshami M; Jaber I; Alser M; Al-Slaibi I; Jabr H; Ubaiat S; Tuffaha A; Khader S; Khraishi R; Arafeh ZA; Al-Madhoun S; Alqattaa A; Yaseen A; El Hadi AA; Barhoush O; Hijazy M; Eleyan T; Alser A; Hziema AA; Shatat A; Almakhtoob F; Mohamad B; Farhat W; Abuamra Y; Mousa H; Adawi R; Musallam A; Albarqi SI; Abu-El-Noor N; Bottcher B
    BMC Public Health; 2024 Apr; 24(1):1027. PubMed ID: 38609950
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Cabozantinib in patients with unresectable and progressive metastatic phaeochromocytoma or paraganglioma (the Natalie Trial): a single-arm, phase 2 trial.
    Jimenez C; Habra MA; Campbell MT; Tamsen G; Cruz-Goldberg D; Long J; Bassett R; Dantzer R; Balderrama-Brondani V; Varghese J; Lu Y
    Lancet Oncol; 2024 May; 25(5):658-667. PubMed ID: 38608693
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. An enzyme-free sensing platform for miRNA detection and in situ imaging in clinical samples based on DNAzyme cleavage-triggered catalytic hairpin assembly.
    Wang H; Shen M; Shen X; Liu J; Huang W; Jiang X; Liu H; Zeng S; Nan K; Cai S
    Biosens Bioelectron; 2024 Jul; 256():116279. PubMed ID: 38608496
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Short- and long-term outcomes after distal pancreatectomy with radiologic infiltration of splenic vessels for pancreatic ductal adenocarcinoma.
    Blanco-Fernández G; Serradilla-Martín M; Rotellar F; Latorre R; Jaén-Torrejimeno I; Muñoz-Forner E; Villodre C; Carabias-Hernández A; Kälviäinen-Mejía HK; Gordillo SE; de la Plaza R; Armas-Conde N; Garcés-Albir M; Morote SC; Manuel-Vázquez A; Serrablo A; Pardo F; Sabater L; Muñoz MPS; Ramia JM
    J Gastrointest Surg; 2024 Apr; 28(4):467-473. PubMed ID: 38583897
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Predictors of recurrence after total thyroidectomy in 1,611 patients with papillary thyroid carcinoma: postoperative stimulated serum thyroglobulin and ATA initial and dynamic risk assessment.
    Ywata de Carvalho A; Kohler HF; Ywata de Carvalho CCG; Vartanian JG; Kowalski LP
    Arch Endocrinol Metab; 2024 Apr; 68():e220506. PubMed ID: 38578436
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A study on the correlations of PRL levels with anxiety, depression, sleep, and self-efficacy in patients with prolactinoma.
    Miao X; Fu Z; Luo X; Wang J; Yuan L; Zhao S; Feng Y; Huang S; Xiao S
    Front Endocrinol (Lausanne); 2024; 15():1369729. PubMed ID: 38572480
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Radioactive iodine administration is not associated with improved disease-specific survival in classic papillary thyroid carcinoma greater than 4 cm confined to the thyroid.
    Lee-Saxton YJ; Palacardo F; Greenberg JA; Egan CE; Marshall TE; Tumati A; Beninato T; Zarnegar R; Fahey TJ; Finnerty BM
    Surgery; 2024 Jan; 175(1):215-220. PubMed ID: 38563429
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Subsequent management and outcomes after first-line PARP inhibitors progression in ovarian cancer patients.
    Yuan H; Li N; Wu L; Yao H
    J Ovarian Res; 2024 Apr; 17(1):70. PubMed ID: 38561819
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. PMFFNet: A hybrid network based on feature pyramid for ovarian tumor segmentation.
    Li L; He L; Guo W; Ma J; Sun G; Ma H
    PLoS One; 2024; 19(4):e0299360. PubMed ID: 38557660
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 328.